Loading insider details...
Beta
Latest Form 4 (Oct 13, 2026): Conversion of 12,517 RTSN shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 13, 2026 | Retension Pharmaceuticals, Inc. (RTSN) | Conversion | 12,517 | n/a |
| Jun 23, 2026 | Atea Pharmaceuticals, Inc. (AVIR) | Exercise/Conversion | 29,600 | n/a |
| May 11, 2026 | Kezar Life Sciences, Inc. (KZR) | Tender of Shares | 89,069 | n/a |
| Oct 15, 2025 | ESSA Pharma Inc. (EPIX) | Disposition to Issuer | 784,404 | n/a |
| Jun 24, 2025 | Atea Pharmaceuticals, Inc. (AVIR) | Exercise/Conversion | 29,600 | n/a |
| Jun 23, 2025 | Kezar Life Sciences, Inc. (KZR) | Grant/Award | 5,000 | n/a |
| Jan 17, 2025 | Atea Pharmaceuticals, Inc. (AVIR) | Purchase | 15,000 | $47.9K |
| Dec 12, 2024 | Atea Pharmaceuticals, Inc. (AVIR) | Sale | 359,606 | $1.02M |
| Jun 21, 2024 | Atea Pharmaceuticals, Inc. (AVIR) | Grant/Award | 29,600 | n/a |
| Jun 21, 2024 | Kezar Life Sciences, Inc. (KZR) | Grant/Award | 50,000 | n/a |